201 related articles for article (PubMed ID: 28279529)
21. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
Gurung AB; Mayengbam B; Bhattacharjee A
Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
[TBL] [Abstract][Full Text] [Related]
22. Constituents of the seeds of Cassia tora with inhibitory activity on soluble expoxide hydrolease.
Lee GY; Kim JH; Choi SK; Kim YH
Bioorg Med Chem Lett; 2015 Nov; 25(22):5097-101. PubMed ID: 26483136
[TBL] [Abstract][Full Text] [Related]
23. Soluble Epoxide Hydrolase Inhibitory Activity of Selaginellin Derivatives from Selaginella tamariscina.
Kim JH; Cho CW; Tai BH; Yang SY; Choi GS; Kang JS; Kim YH
Molecules; 2015 Dec; 20(12):21405-14. PubMed ID: 26633335
[TBL] [Abstract][Full Text] [Related]
24. A new phenolic derivative with soluble epoxide hydrolase and nuclear factor-kappaB inhibitory activity from the aqueous extract of Acacia catechu.
Sun YN; Li W; Song SB; Yan XT; Zhao Y; Jo AR; Kang JS; Young Ho K
Nat Prod Res; 2016 Sep; 30(18):2085-92. PubMed ID: 26647286
[TBL] [Abstract][Full Text] [Related]
25. Discovery of Potent Soluble Epoxide Hydrolase (sEH) Inhibitors by Pharmacophore-Based Virtual Screening.
Waltenberger B; Garscha U; Temml V; Liers J; Werz O; Schuster D; Stuppner H
J Chem Inf Model; 2016 Apr; 56(4):747-62. PubMed ID: 26882208
[TBL] [Abstract][Full Text] [Related]
26. Chemical constituents from the root of Polygonum multiflorum and their soluble epoxide hydrolase inhibitory activity.
Sun YN; Li W; Kim JH; Yan XT; Kim JE; Yang SY; Kim YH
Arch Pharm Res; 2015 Jun; 38(6):998-1004. PubMed ID: 25413971
[TBL] [Abstract][Full Text] [Related]
27. Soluble epoxide hydrolase inhibitory activity of components from Leonurus japonicus.
Leem HH; Lee GY; Lee JS; Lee H; Kim JH; Kim YH
Int J Biol Macromol; 2017 Oct; 103():451-457. PubMed ID: 28501602
[TBL] [Abstract][Full Text] [Related]
28. Protostane-type triterpenoids as natural soluble epoxide hydrolase inhibitors: Inhibition potentials and molecular dynamics.
Sun CP; Zhang J; Zhao WY; Yi J; Yan JK; Wang YL; Morisseau C; Liu ZB; Hammock BD; Ma XC
Bioorg Chem; 2020 Mar; 96():103637. PubMed ID: 32032849
[TBL] [Abstract][Full Text] [Related]
29. Natural soluble epoxide hydrolase inhibitors from Alisma orientale and their potential mechanism with soluble epoxide hydrolase.
Zhao WY; Zhang XY; Zhou MR; Tian XG; Lv X; Zhang HL; Deng S; Zhang BJ; Sun CP; Ma XC
Int J Biol Macromol; 2021 Jul; 183():811-817. PubMed ID: 33957203
[TBL] [Abstract][Full Text] [Related]
30. Two new chemical constituents from the rhizomes of
Ma SJ; Li HB; Shao JR; Pang QQ; Li T; Yao XS; Yu Y
Nat Prod Res; 2022 Apr; 36(7):1789-1796. PubMed ID: 32911990
[TBL] [Abstract][Full Text] [Related]
31. Discovery of polar spirocyclic orally bioavailable urea inhibitors of soluble epoxide hydrolase.
Lukin A; Kramer J; Hartmann M; Weizel L; Hernandez-Olmos V; Falahati K; Burghardt I; Kalinchenkova N; Bagnyukova D; Zhurilo N; Rautio J; Forsberg M; Ihalainen J; Auriola S; Leppänen J; Konstantinov I; Pogoryelov D; Proschak E; Dar'in D; Krasavin M
Bioorg Chem; 2018 Oct; 80():655-667. PubMed ID: 30059891
[TBL] [Abstract][Full Text] [Related]
32. Adamantyl thioureas as soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Pitushkin D; Karlov D; Fayzullin RR; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2018 Jul; 28(13):2302-2313. PubMed ID: 29803731
[TBL] [Abstract][Full Text] [Related]
33. Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophores.
Scholz MS; Wingen LM; Brunst S; Wittmann SK; Cardoso ILA; Weizel L; Proschak E
Eur J Med Chem; 2020 Jan; 185():111766. PubMed ID: 31677445
[TBL] [Abstract][Full Text] [Related]
34. Probing ligand-binding modes and binding mechanisms of benzoxazole-based amide inhibitors with soluble epoxide hydrolase by molecular docking and molecular dynamics simulation.
Chen H; Zhang Y; Li L; Han JG
J Phys Chem B; 2012 Aug; 116(34):10219-33. PubMed ID: 22857012
[TBL] [Abstract][Full Text] [Related]
35. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.
Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD
Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552
[TBL] [Abstract][Full Text] [Related]
36. Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Lee KS; Shihadih DS; Harris TR; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2014 May; 24(9):2193-7. PubMed ID: 24685540
[TBL] [Abstract][Full Text] [Related]
37. One new and seven known triterpene glycosides from the aerial parts of
Hao YM; Luo W; Jiang GZ; Lv CN; Lu JC
J Asian Nat Prod Res; 2020 Aug; 22(8):788-793. PubMed ID: 31357881
[TBL] [Abstract][Full Text] [Related]
38. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.
Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S
Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory Activity of Quercetin 3-
Cho IS; Kim JH; Lin Y; Su XD; Kang JS; Yang SY; Kim YH
Molecules; 2020 Sep; 25(18):. PubMed ID: 32972033
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.
Morisseau C; Pakhomova S; Hwang SH; Newcomer ME; Hammock BD
Bioorg Med Chem Lett; 2013 Jul; 23(13):3818-21. PubMed ID: 23684894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
